Andrea Perra
Overview
Explore the profile of Andrea Perra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smiriglia A, Lorito N, Bacci M, Subbiani A, Bonechi F, Comito G, et al.
Cell Death Dis
. 2025 Jan;
16(1):57.
PMID: 39890799
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of hepatic disorders, ranging from simple steatosis to steatohepatitis, with the most severe outcomes including cirrhosis, liver failure, and hepatocellular carcinoma....
2.
Littera R, Mocci S, Argiolas D, Littarru L, Lai S, Melis M, et al.
Front Immunol
. 2024 Nov;
15:1440887.
PMID: 39575256
Background: Antibody-mediated rejection is a significant cause of kidney transplant failure. Recent studies have shown that the MHC class I gene influences the transplantation outcome. However, the role of the...
3.
Costanzo G, Sanna G, Pes F, Deiana C, Ledda A, Perra A, et al.
Pathogens
. 2024 Jun;
13(6).
PMID: 38921803
Immunization against COVID-19 is needed in patients with immune-mediated inflammatory diseases (IMIDs). However, data on long-term immunity kinetics remain scarce. This study aimed to compare the humoral and cellular response...
4.
Dus-Ilnicka I, Paradowska-Stolarz A, Mazur M, Radwan-Oczko M, Perra A, de Paula V, et al.
BMC Med Educ
. 2024 Mar;
24(1):352.
PMID: 38553736
Blended Intensive Programmes (BIP's) represent a valuable tool for gathering knowledge and summarising the latest trends in medicine and dentistry. Blended education has been found, even before the COVID-19 pandemic,...
5.
Dus-Ilnicka I, Halon A, Perra A, Radwan-Oczko M
BMC Oral Health
. 2024 Mar;
24(1):347.
PMID: 38500158
Background: The association of Human Papilloma Virus (HPV) and Human Syncytial Virus (HSV) infection with inflammatory and potentially malignant disorders of the oral cavity (OPMD) is unknown. The aim of...
6.
Sanna G, Marongiu A, Firinu D, Piras C, Palmas V, Galdiero M, et al.
Clin Exp Med
. 2024 Jan;
24(1):12.
PMID: 38244064
Several countries have recommended a booster dose of Pfizer BNT162b2 vaccine for subjects under the age of 60, who have already received the first dose of ChAdOx1. This is due...
7.
Costanzo G, Deiana C, Sanna G, Perra A, Campagna M, Ledda A, et al.
J Clin Immunol
. 2023 Dec;
44(1):12.
PMID: 38129351
Purpose: The purpose of this study is to investigate the kinetics of response against SARS-CoV-2 elicited by vaccination and/or breakthrough infection (occurred after 3 doses of BNT162b2) in a cohort...
8.
Smiriglia A, Lorito N, Serra M, Perra A, Morandi A, Kowalik M
iScience
. 2023 Nov;
26(12):108363.
PMID: 38034347
Only a few preclinical findings are confirmed in the clinic, posing a critical issue for clinical development. Therefore, identifying the best preclinical models can help to dissect molecular and mechanistic...
9.
Kowalik M, Taguchi K, Serra M, Caddeo A, Puliga E, Bacci M, et al.
Hepatology
. 2023 Aug;
79(4):829-843.
PMID: 37603610
Background And Aims: Cancer cells reprogram their metabolic pathways to support bioenergetic and biosynthetic needs and to maintain their redox balance. In several human tumors, the Keap1-Nrf2 system controls proliferation...
10.
Pisano F, Cannas B, Fanni A, Pasella M, Canetto B, Giglio S, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1230733.
PMID: 37601789
Introduction: Few artificial intelligence models exist to predict severe forms of COVID-19. Most rely on post-infection laboratory data, hindering early treatment for high-risk individuals. Methods: This study developed a machine...